Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.37 |
| ▸ | GRM8 | O00222 | 1/20 | 0.36 |
| ▸ | GRM6 | O15303 | 1/20 | 0.36 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.36 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.36 |
| ▸ | GSR | P00390 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9400987 | 1.00 | TDP1 (0.42) | TDP1MEN1KMT2ASMN1; SMN2CYP2D6 | |
| SCHEMBL18165414 | 0.83 | SLC7A5 (0.39) | TDP1MEN1KMT2ACYP2D6CYP2C9 | |
| SCHEMBL29234456 | 0.83 | SLC7A5 (0.39) | TDP1MEN1KMT2ACYP2D6CYP2C9 | |
| SCHEMBL29961107 | 0.78 | SLC22A6 (0.50) | TDP1MEN1KMT2ASMN1; SMN2CYP2C9 | |
| SCHEMBL5146070 | 0.76 | FOLH1 (0.54) | MEN1KMT2ACYP2D6CYP2C19LMNA | |
| SCHEMBL6046246 | 0.75 | — | — | |
| SCHEMBL5323585 | 0.75 | — | — | |
| SCHEMBL8835142 | 0.74 | TDP1 (0.53) | TDP1MEN1KMT2ASMN1; SMN2CYP2C9 | |
| SCHEMBL22228590 | 0.74 | TDP1 (0.46) | TDP1MEN1KMT2ASMN1; SMN2CYP2D6 | |
| SCHEMBL22228588 | 0.74 | TDP1 (0.46) | TDP1MEN1KMT2ASMN1; SMN2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118062826-A | High-capacity asphalt-based hard carbon material, preparation method and application thereof | 梧州市同创新能源材料有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-117673353-A | Hard carbon composite material for sodium ion battery and preparation method thereof | 丰镇市宏升炭素有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-118062826-A | High-capacity asphalt-based hard carbon material, preparation method and application thereof | 梧州市同创新能源材料有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-117673353-A | Hard carbon composite material for sodium ion battery and preparation method thereof | 丰镇市宏升炭素有限公司 | 2024-03-08 | — | — | CN | disclosed |
| US-11318095-B2 | Micelle for solubilizing a sparingly water-soluble ingredient and solution comprising the same | TEIKA PHARMACEUTICAL CO., LTD. (JP) | 2022-05-03 | — | — | US | disclosed |
| US-20210137836-A1 | MICELLE FOR SOLUBILIZING A SPARINGLY WATER-SOLUBLE INGREDIENT AND SOLUTION COMPRISING THE SAME | TEIKA PHARMACEUTICAL CO., LTD. (JP) | 2021-05-13 | — | — | US | disclosed |
| US-5317021-A | Analgesics, anticonvulsants | ONO PHARMACEUTICAL CO., LTD. (JP) | 1994-05-31 | — | — | US | disclosed |
| US-5085856-A | Containing water, waxes, oils to provide moisturisation, protection | ELIZABETH ARDEN CO., DIVISION OF CONOPCO, INC. (US) | 1992-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210137836-A1 | MICELLE FOR SOLUBILIZING A SPARINGLY WATER-SOLUBLE INGREDIENT AND SOLUTION COMPRISING THE SAME | CETP, LIPA, MUC1 | TDP1 2344/4885MEN1 593/4885KMT2A 3708/4885 |
| US-11318095-B2 | Micelle for solubilizing a sparingly water-soluble ingredient and solution comprising the same | CETP, LIPA, MUC1 | TDP1 2344/4885MEN1 593/4885KMT2A 3708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.